Magnetic separation is a promising alternative to chromatography
for enhancing the downstream processing (DSP) of monoclonal antibodies
(mAbs). However, there is a lack of efficient magnetic particles for
successful application. Aiming to fill this gap, we demonstrate the
suitability of bare iron oxide nanoparticles (BION) with physical
site-directed immobilization of an engineered Protein A affinity ligand
(rSpA) as an innovative magnetic material. The rSpA ligand contains
a short peptide tag that enables the direct and stable immobilization
onto the uncoated BION surface without commonly required laborious
particle activation. The resulting BION@rSpA have beneficial characteristics
outperforming conventional Protein A-functionalized magnetic particles:
a simple, fast, low-cost synthesis, a particle size in the nanometer
range with a large effective specific surface area enabling large
immunoglobulin G (IgG) binding capacity, and a high magnetophoretic
velocity advantageous for fast processing. We further show rapid interactions
of IgG with the easily accessible rSpA ligands. The binding of IgG
to BION@rSpA is thereby highly selective and not impeded by impurity
molecules in perfusion cell culture supernatant. Regarding the subsequent
acidic IgG elution from BION@rSpA@IgG, we observed a hampering pH
increase caused by the protonation of large iron oxide surfaces after
concentrating the particles in 100 mM sodium acetate buffer. However,
the pH can be stabilized by adding 50 mM glycine to the elution buffer,
resulting in recoveries above 85% even at high particle concentrations.
Our work shows that BION@rSpA enable efficient magnetic mAb separation
and could help to overcome emerging bottlenecks in DSP.